763D Concord Avenue
Ultivue develops innovative reagent-based solutions that maximize the biological information available from cells and tissue samples. The company’s patent-pending technology is being used to elucidate biological pathways and to validate clinically-relevant biomarkers. Ultivue is based in Cambridge, MA.
Co-Founder: Peng Yin
Co-Founder: David Walt
Co-Founder: Ralf Jungmann
CTO: Michael Natan
Please click here for Ultivue job opportunities.
Please click here for Ultivue's products.